Despina Psillides, MD
Geriatric Medicine · Flemington, NJNPI 1174758668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 118 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$259
- Amgen$206
- Novo Nordisk$201
- Lilly USA, LLC$178
- Lundbeck LLC$156
- GSK$146
- plus $747 from 24 others
What the payments were for
- Food & beverage$1,87899%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $259 |
| Amgen | 14 | $206 |
| Novo Nordisk | 12 | $201 |
| Lilly USA, LLC | 10 | $178 |
| Lundbeck LLC | 9 | $156 |
| GSK | 9 | $146 |
| Johnson & Johnson | 5 | $82 |
| Merck | 5 | $77 |
| Exact Sciences | 3 | $66 |
| Amneal Pharmaceuticals LLC | 4 | $56 |
| Amarin Pharma, Inc. | 4 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Corcept Therapeutics | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| AstraZeneca(2 entities) | 2 | $28 |
| Bayer | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Zealand Pharma US, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Mannkind Corporation | 1 | $15 |
| Novartis | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,892 in reported general payments places this provider in the 75th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $41,385 |
| XareltoRivaroxaban | 34 | $33,936 |
| JanuviaSitagliptin Phosphate | 15 | $20,269 |
| JardianceEmpagliflozin | 19 | $18,978 |
| MyrbetriqMirabegron | 23 | $17,790 |
| VasotecEnalapril Maleate | 13 | $17,603 |
| TrulicityDulaglutide | 12 | $11,408 |
| OzempicSemaglutide | 12 | $11,373 |
| TradjentaLinagliptin | 14 | $7,566 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,114 |
| Atorvastatin Calcium | 253 | $3,719 |
| Levothyroxine Sodium | 211 | $2,829 |
| Pantoprazole Sodium | 131 | $2,471 |
| Mesalamine DrMesalamine | 11 | $2,452 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $1,811 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $41,38551 claims |
| Johnson & JohnsonXarelto | $82 | $33,93634 claims |
| Boehringer IngelheimJardiance, Tradjenta | $15 | $26,54533 claims |
| MerckJanuvia | $77 | $20,26915 claims |
| Lilly USA, LLCTrulicity | $178 | $11,40812 claims |
| Novo NordiskOzempic | $201 | $11,37312 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $19 | $6,11412 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $56 | $2,829211 claims |
| AbbVieSynthroid | $259 | $1,54624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Flemington
- Seshadri ChakravarthiFlemington$2K
- Larisa GolubFlemington$798
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.